Condition: Gastrointenstinal Stromal Tumor (GIST) · Sponsor: The First Affiliated Hospital with Nanjing Medical University
This study is a prospective, multicenter, single-arm, phase II clinical trial. It plans to enroll 182 patients with localized gastric gastrointestinal stromal tumors (GISTs) at special anatomic sites. Eligible patients who meet the inclusion/exclusion criteria and provide written informed consent will undergo robotic radical surgery. Postoperative treatment will be determined jointly by the clinicians and patients based on actual clinical practice.
This description comes directly from the study's public registry record.
Qiang Zhang, Ph.D · +86 18851727696 · zhqsq@qq.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital) | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07405125